Hoarding Disorder: Neurobiology, Assessment, CBT Protocol, and Motivational Interviewing — A Clinical Deep Dive

Hoarding disorder (HD) was elevated to a standalone diagnosis in the DSM-5 (2013), classified under the Obsessive-Compulsive and Related Disorders chapter — a move reflecting decades of accumulating evidence that hoarding is neurobiologically, phenomenologically, and therapeutically distinct from obsessive-compulsive disorder (OCD). The ICD-11 followed suit, recognizing hoarding disorder as a separate condition (code 6B24). Prior to this reclassification, hoarding was subsumed under the OCD diagnosis or, in some conceptualizations, under obsessive-compulsive personality disorder (OCPD), an arrangement that obscured its unique pathophysiology and led to systematic underdiagnosis and mistreatment.

The DSM-5-TR diagnostic criteria require: (A) persistent difficulty discarding or parting with possessions, regardless of actual value; (B) the difficulty is due to a perceived need to save items and distress associated with discarding them; (C) the accumulation of possessions congests and clutters active living areas, substantially compromising their intended use (unless third-party interventions such as family members, cleaners, or authorities have cleared the space); (D) the hoarding causes clinically significant distress or impairment in social, occupational, or other important areas of functioning (including maintaining a safe environment for self and others); (E) the hoarding is not attributable to another medical condition (e.g., brain injury, cerebrovascular disease, Prader-Willi syndrome); and (F) the hoarding is not better explained by the symptoms of another mental disorder (e.g., obsessions in OCD, decreased energy in major depressive disorder, delusions in psychotic disorders, cognitive deficits in major neurocognitive disorder, restricted interests in autism spectrum disorder).

Two specifiers are available: with excessive acquisition (present in approximately 80–90% of individuals with HD), and an insight specifier ranging from good or fair insight, to poor insight, to absent insight/delusional beliefs about hoarding-related behaviors. The insight specifier is clinically pivotal because the majority of individuals with HD — estimated at 60–80% — present with poor or absent insight, a rate substantially higher than seen in OCD (where most patients recognize their obsessions as excessive). This insight deficit has profound implications for treatment engagement and outcome.

Population-based estimates consistently place the point prevalence of hoarding disorder between 2% and 6% of the adult population, with most well-designed community surveys converging around 2.5–5%. This makes HD approximately two to three times more prevalent than OCD (which has a lifetime prevalence of roughly 2–3%). The London epidemiological study by Nordsletten et al. (2013), using a large nationally representative sample from Sweden (N > 15,000), estimated a prevalence of approximately 2.4%. A German epidemiological study by Mueller et al. (2009) found clinically significant hoarding symptoms in approximately 5.8% of the population. The Timpano et al. (2011) meta-analysis of prevalence studies reported a weighted average around 2.5%, though methodological variability across studies was substantial.

Several demographic patterns are well-established. HD affects men and women at roughly equal rates in community samples, though clinical samples tend to over-represent women — likely reflecting help-seeking patterns rather than true sex differences. This contrasts with earlier clinical lore that hoarding was predominantly female. The disorder shows a characteristic age-of-onset pattern: subclinical hoarding behaviors typically begin in childhood or early adolescence (mean onset approximately 11–15 years), but clinically significant impairment usually does not manifest until the third or fourth decade of life, with severity increasing monotonically with age. Prevalence is roughly three times higher in adults over age 55 compared to younger adults, though this likely reflects cumulative acquisition over decades rather than late-onset pathology.

The public health burden of HD is substantial and underappreciated. Hoarding is associated with significantly elevated risk of falls, fire, unsanitary living conditions, eviction, and social isolation. A study by Tolin et al. (2008) estimated that hoarding was identified in approximately 25% of residential fire deaths. The economic costs — including emergency services, code enforcement, social services, and lost productivity — are considerable, though comprehensive cost-of-illness studies remain scarce. Municipalities increasingly recognize hoarding as a public health concern requiring coordinated multi-agency task forces.

The neurobiology of hoarding disorder diverges meaningfully from that of OCD, supporting its diagnostic separation. Functional neuroimaging studies have implicated dysfunction in several interconnected neural circuits, with the most consistent findings involving the ventromedial prefrontal cortex (vmPFC), the anterior cingulate cortex (ACC), and the insula.

Prefrontal and Cingulate Dysfunction

The landmark neuroimaging study by Tolin et al. (2012), published in Archives of General Psychiatry, used a provocation paradigm in which individuals with HD (n=43), individuals with OCD (n=31), and healthy controls (n=33) were asked to make decisions about discarding their own possessions versus control objects. When deciding about their own possessions, the HD group showed aberrant activation in the ACC and insula — specifically, hypoactivation when processing others' possessions (suggesting diminished salience detection) and hyperactivation when processing their own possessions (suggesting excessive emotional attachment and threat-related processing). This pattern of context-dependent abnormal activation was unique to HD and was not observed in the OCD group. The ACC, critical for error monitoring, conflict detection, and effort-based decision-making, appears to generate excessive distress signals during discard decisions. The vmPFC, involved in value-based decision-making and emotional regulation, shows functional abnormalities consistent with the pronounced difficulty HD patients have in assessing the actual utility or value of objects.

Insular Cortex and Emotional Attachment

The anterior insula, a hub for interoceptive awareness and emotional salience, consistently shows heightened reactivity in HD during discard paradigms. This hyperactivation is thought to underlie the intense visceral distress — often described as a physical sense of loss or grief — that individuals with HD report when contemplating discarding possessions. This is consistent with theoretical models proposing that objects become extensions of the self in HD, such that discarding feels akin to losing a part of one's identity.

Executive Functioning and Information Processing

Neuropsychological studies have documented deficits in categorization, decision-making, sustained attention, and working memory in HD. A meta-analysis by Blom et al. (2011) confirmed moderate effect sizes for executive dysfunction, particularly in tasks requiring organization and categorical sorting. These deficits align with the commonly observed clinical phenomenon in which individuals with HD create elaborate but idiosyncratic organizational systems, or avoid organizing entirely due to decision paralysis. Dorsolateral prefrontal cortex (dlPFC) hypoactivation during organizational tasks has been observed in some studies, though findings are less consistent than the vmPFC/ACC/insula triad.

Neurotransmitter Systems

The neurochemistry of HD is less well-characterized than its neuroanatomy, but several lines of evidence are informative. The serotonergic system appears involved, though the low response rate to SSRIs in HD (discussed below) suggests that serotonin dysfunction alone is insufficient to explain the disorder. Dopaminergic pathways, particularly mesolimbic reward circuits, are implicated by the excessive acquisition component — the acquisition itself (shopping, collecting, picking up free items) is associated with dopamine-mediated reward activation, while the failure to discard may reflect abnormal loss aversion mediated by noradrenergic and serotonergic systems. Animal models of hoarding behavior in rodents have implicated the nucleus accumbens and dopaminergic signaling, though the translational relevance to human HD is uncertain. The role of the noradrenergic system is suggested by the attentional and executive deficits common in HD, and by the partial overlap with ADHD.

Genetic Factors

Hoarding disorder has a significant heritable component. Twin studies estimate heritability at approximately 50%, with the remainder attributable to non-shared environmental factors. Family studies consistently show that approximately 50–85% of individuals with HD report a first-degree relative with significant hoarding behaviors. The first genome-wide association study (GWAS) of hoarding, conducted by Mathews et al. (2014), identified a suggestive linkage on chromosome 14q near the gene MAPK5 (involved in intracellular signaling), though no loci reached genome-wide significance, likely due to limited sample size. A GWAS by Burton et al. (2021) using UK Biobank data identified a locus near TXNRD1 on chromosome 12. Candidate gene studies have examined polymorphisms in SLC1A1 (glutamate transporter), COMT (catechol-O-methyltransferase, affecting dopamine degradation), and 5-HTTLPR (serotonin transporter), but findings have not been consistently replicated. The genetic architecture of HD appears polygenic, with many common variants of small effect, and there is growing interest in shared genetic liability with ADHD and major depressive disorder.

Accurate assessment of hoarding disorder requires a multi-method approach combining structured clinical interview, self-report measures, behavioral observation (ideally including a home visit), and informant report — the latter being particularly important given the high rates of poor insight in this population.

Core Assessment Instruments

The Saving Inventory-Revised (SI-R) (Frost, Steketee, & Grisham, 2004) is the most widely used and best-validated self-report measure for hoarding severity. This 23-item questionnaire yields three subscale scores — Excessive Acquisition, Difficulty Discarding, and Clutter — as well as a total score. The clinical cutoff for the total score is generally set at ≥ 41, with good sensitivity and specificity. The SI-R has strong psychometric properties (internal consistency α = .92; test-retest reliability r = .87) and is sensitive to treatment change, making it suitable as both a diagnostic screener and an outcome measure.

The Hoarding Rating Scale (HRS) (Tolin, Frost, & Steketee, 2010) is a brief 5-item clinician- or self-rated measure assessing clutter, difficulty discarding, excessive acquisition, distress, and impairment. It is efficient for screening and for tracking progress across treatment sessions. A total score ≥ 14 has been proposed as the clinical threshold.

The Clutter Image Rating (CIR) (Frost et al., 2008) is a visual assessment tool consisting of photographs of rooms at nine levels of clutter severity (rated 1–9 for the kitchen, living room, and bedroom). The CIR is particularly valuable because it provides a concrete, standardized anchor for clutter severity that helps circumvent the minimization and insight deficits common in HD. A CIR average score ≥ 4 is generally considered to indicate clinically significant clutter.

The Structured Interview for Hoarding Disorder (SIHD) and the Hoarding Disorder Module of structured clinical interviews (e.g., the SCID-5) provide comprehensive DSM-5-TR aligned diagnostic assessment. The UCLA Hoarding Severity Scale (UHSS) is a 10-item clinician-administered instrument that has also gained traction.

The Insight Problem

As noted, the majority of HD patients present with poor or absent insight. This creates a fundamental assessment challenge: self-report measures may substantially underestimate symptom severity. Clinicians should routinely incorporate informant reports (from family members, social workers, or housing authorities) and, whenever possible, conduct home assessments. In-home assessment allows the clinician to directly observe clutter levels, squalor (which is not synonymous with clutter), health hazards, and the degree to which living spaces have lost their intended function. Remote assessment via video call or patient-submitted photographs has emerged as a pragmatic alternative, particularly since the COVID-19 pandemic expanded telehealth use.

Differential Diagnosis

Differential diagnosis requires careful distinction from several conditions:

• OCD with hoarding-related obsessions: In OCD, saving is driven by specific obsessional content (e.g., contamination fears about discarded items, symmetry/completeness needs) and is experienced as ego-dystonic. In HD, saving is motivated by perceived utility, aesthetic appreciation, or emotional attachment, and is often ego-syntonic.
• Major depressive disorder: Severe depression can produce clutter through amotivation, psychomotor retardation, and neglect. If hoarding behaviors resolve when the depression remits, HD should not be diagnosed.
• ADHD: Attentional and organizational deficits in ADHD can produce significant clutter and disorganization. However, ADHD-related clutter typically lacks the intense emotional attachment to objects and the distress upon discarding that characterize HD. The two conditions frequently co-occur (see comorbidity section), complicating this distinction.
• Major neurocognitive disorder: Accumulation behavior can occur in frontotemporal dementia and other dementias. The onset pattern and cognitive profile help distinguish these cases.
• Autism spectrum disorder: Restricted interests may lead to collecting behaviors that can resemble hoarding. The motivation (circumscribed interest vs. generalized difficulty discarding) helps differentiate.
• Prader-Willi syndrome and other medical conditions: Hoarding-like behaviors have been described in Prader-Willi syndrome, post-traumatic brain injury, and after strokes affecting the anterior cingulate or mesial frontal regions.

Hoarding disorder is highly comorbid with other psychiatric conditions, a pattern that significantly complicates treatment and worsens prognosis. The most common comorbidities, with approximate prevalence estimates in HD clinical samples, include:

• Major depressive disorder (MDD): 50–75% lifetime prevalence in HD samples, making it the single most common comorbidity. The relationship appears bidirectional — the functional impairment and social isolation caused by hoarding contribute to depression, while depression exacerbates amotivation and decision-making difficulties.
• Generalized anxiety disorder (GAD): 25–40%. Worry about the consequences of discarding, about future need for items, and about making incorrect decisions is pervasive in HD.
• Social anxiety disorder: 15–30%. Many individuals with HD avoid social contact and refuse to allow visitors due to embarrassment about their living conditions, creating a self-reinforcing cycle of isolation.
• ADHD: 20–30%. This is a clinically important comorbidity because the executive function deficits in ADHD (particularly inattention, disorganization, and difficulty completing tasks) directly exacerbate hoarding symptoms. Hartl et al. (2005) and others have documented elevated rates of inattention symptoms in HD, and some patients report that their clutter is as much a product of disorganization as of inability to discard.
• OCD: 15–20%. Despite the diagnostic separation, HD and OCD co-occur at rates above chance. When both are present, each requires separate treatment targeting.
• OCPD: 20–35%. Traits of perfectionism, rigidity, and difficulty delegating are common in HD and likely contribute to the procrastination and decision avoidance that maintain clutter.
• PTSD and trauma history: 20–30%. A significant subset of HD patients report traumatic life events — particularly material deprivation (e.g., poverty, wartime scarcity) or interpersonal loss — that appear to function as precipitating or maintaining factors for hoarding. Possessions may serve a safety/security function in these individuals.

The cumulative comorbidity burden is substantial: most individuals with HD in clinical settings meet criteria for at least one and often two or more additional psychiatric diagnoses. This comorbidity is clinically consequential — comorbid depression predicts worse treatment response, comorbid ADHD undermines the organizational skills needed for CBT homework, and comorbid social anxiety impairs group treatment engagement.

The most extensively studied and empirically supported psychotherapy for hoarding disorder is the cognitive-behavioral therapy (CBT) protocol developed by Gail Steketee and Randy Frost, described in their treatment manual Buried in Treasures (for bibliotherapy) and in the clinician manual Treatment for Hoarding Disorder (2nd edition, 2014). This specialized protocol was developed specifically for HD and differs substantially from standard OCD-focused CBT (i.e., exposure and response prevention alone is insufficient for HD).

Components of the Protocol

The Steketee-Frost CBT protocol is typically delivered over 26 sessions (approximately 6–7 months), though some research protocols use abbreviated formats of 16–20 sessions. The treatment integrates several key components:

• Psychoeducation and case formulation: Understanding the cognitive-behavioral model of HD — how emotional attachment to objects, erroneous beliefs about possessions, and avoidance of discard decisions maintain the hoarding cycle.
• Motivational enhancement: Given the high rates of poor insight and ambivalence in HD, motivational interviewing (MI) techniques are embedded throughout the protocol, particularly in the early sessions. The goal is to build intrinsic motivation for change by exploring the discrepancy between the patient's values (e.g., safety, family relationships, health) and the consequences of their hoarding behavior.
• Cognitive restructuring: Targeting the specific cognitive distortions that maintain hoarding, including overestimation of the importance of possessions ("I might need this someday"), emotional reasoning about objects ("This feels too important to discard"), excessive responsibility for objects ("It would be wasteful to throw this away"), and perfectionism about decision-making ("I need to find the perfect way to dispose of each item").
• Skills training: Explicit instruction and practice in organizational and decision-making skills — including categorization strategies, the development of sorting rules, and the creation of sustainable organizational systems. This directly targets the executive function deficits observed in HD.
• Exposure and behavioral experiments: Graduated exposure to discarding, non-acquiring, and tolerating the distress associated with both. Unlike OCD-focused ERP, the exposures in HD-focused CBT are integrated with cognitive work and skills training rather than being the sole therapeutic mechanism. Behavioral experiments test catastrophic predictions (e.g., "If I discard this, I will desperately need it and be unable to cope").
• In-session and between-session sorting practice: A critical component in which the therapist guides the patient through actual sorting and discarding of possessions, either in-office (using items brought from home) or during home visits. The inclusion of in-home sessions is strongly recommended, as it provides ecologically valid practice and allows the clinician to assess progress directly.
• Relapse prevention: Developing an ongoing maintenance plan, as HD is a chronic condition with high relapse potential.

Treatment Outcomes

The evidence base for CBT for HD has grown substantially since the early 2000s. Key findings include:

The Steketee et al. (2010) randomized controlled trial — one of the first rigorous RCTs for HD — compared 26 sessions of CBT to a waitlist control. The CBT group showed statistically significant and clinically meaningful reductions on the SI-R (effect size d ≈ 0.8–1.0), with approximately 60–70% of completers showing clinically significant improvement (defined as reliable change exceeding the reliable change index). However, full remission rates were modest, with only approximately 25–35% of treated individuals achieving subclinical SI-R scores by treatment end.

Subsequent studies, including the Tolin et al. (2015) RCT comparing individual CBT to a peer-led bibliotherapy group, confirmed that therapist-led CBT outperformed bibliotherapy, though the bibliotherapy group (using the Buried in Treasures workbook in a facilitated group format) also showed meaningful improvement — approximately 25–30% of participants achieved clinically significant change.

The Muroff et al. (2009) and Frost et al. (2011) studies of the facilitated Buried in Treasures (BIT) group format demonstrated that this lower-cost, higher-access delivery model produces SI-R effect sizes in the range of d = 0.6–0.9, making it a viable community-based option. BIT groups are now widely offered through community mental health centers, peer-support organizations, and task forces.

Meta-analytic data compiled by Tolin et al. (2015) across multiple CBT for HD trials estimated a pooled within-group effect size of approximately d = 1.0–1.1 on self-report hoarding measures, which is considered large. However, the average post-treatment SI-R score in most trials still falls in the clinical or near-clinical range, reflecting that many patients improve but do not fully recover. Response rates (typically defined as ≥ 30% reduction on the SI-R) average 50–60% on an intent-to-treat basis. These response rates are notably lower than those for CBT in OCD (where 60–70% response rates are typical) or in depression.

Dropout rates in HD treatment are a significant concern, typically ranging from 15–25% in research settings and likely higher in routine clinical practice, driven by the insight deficits, ambivalence, and practical barriers (e.g., transportation difficulties, physical health limitations in the older adults who disproportionately present for treatment).

Motivational interviewing (MI) is not merely a useful adjunct in hoarding disorder treatment — it is, for many patients, a prerequisite for any meaningful therapeutic engagement. The high prevalence of poor insight and ego-syntonic symptomatology in HD means that a substantial proportion of patients present in the precontemplation or contemplation stages of change (using the Prochaska and DiClemente transtheoretical model). Many are referred by family members, housing authorities, or adult protective services rather than self-referring, and a significant number initially deny that a problem exists or attribute the problem entirely to others' overreaction.

MI Principles Applied to HD

The core MI principles — expressing empathy, developing discrepancy, rolling with resistance, and supporting self-efficacy — are applied with specific adaptations for HD:

• Expressing empathy requires genuine curiosity about the patient's relationship with their possessions. Many HD patients have been shamed, judged, or forcibly "cleaned out" (an experience that is often traumatic and counterproductive). The therapist's non-judgmental stance is itself therapeutic and may be novel for the patient.
• Developing discrepancy is the central MI intervention for HD. The therapist helps the patient explore how their hoarding behavior conflicts with their core values — for instance, the desire to have grandchildren visit (impossible due to clutter), the wish to cook meals (kitchen is inaccessible), or the goal of maintaining housing (eviction threatened). This values-behavior discrepancy is the engine of intrinsic motivation.
• Rolling with resistance is essential because confrontational approaches — including forceful decluttering, ultimatums, and shaming — reliably produce reactance, entrenchment, and treatment dropout in HD. When a patient insists that every newspaper from 2003 is essential, the therapist does not argue but instead explores the function and meaning of the newspapers.
• Supporting self-efficacy involves identifying and reinforcing any past successes, however small, in discarding or organizing. Many HD patients have deeply impaired self-efficacy around clutter management and need the therapist to scaffold initial success experiences.

Evidence for MI in HD

The evidence base for MI as a standalone treatment for HD is limited, but its integration into CBT protocols is supported by both theoretical rationale and clinical observation. Ayers et al. (2014) tested a combined MI plus behavioral therapy protocol for older adults with HD (the Geriatric Hoarding Intervention), finding significant improvement on the SI-R (d ≈ 0.7) with a treatment specifically designed to address the motivational and physical limitations of elderly hoarders. Gilliam et al. (2011) demonstrated that patients who received MI-enhanced CBT showed better early engagement and higher rates of homework compliance compared to standard CBT, though the studies were small. The Steketee-Frost protocol itself explicitly integrates MI techniques in its first several sessions, reflecting the field's recognition that without motivational work, subsequent cognitive and behavioral interventions are unlikely to gain traction.

A practical clinical consideration: MI in HD often requires more sessions than in other conditions. The ambivalence in HD is typically deep-rooted, ego-syntonic, and reinforced by genuine emotional attachment to possessions. Clinicians should expect that motivational work will continue throughout treatment, not only in an initial "MI phase." The therapeutic alliance in HD is predictive of outcome, and MI is the primary tool for building that alliance.

Pharmacotherapy for hoarding disorder has a substantially weaker evidence base than psychotherapy, and the available data are largely disappointing. Nonetheless, pharmacological interventions play a role in clinical practice, particularly for managing comorbid conditions and augmenting CBT.

SSRIs

The historical assumption — that because hoarding was part of OCD, SSRIs should be effective — has not been borne out. Multiple studies have documented that hoarding symptoms respond to SSRIs at rates substantially lower than other OCD symptoms. The landmark Bloch et al. (2006) meta-analysis of OCD treatment trials found that the presence of hoarding symptoms was a significant predictor of poor response to SRI (serotonin reuptake inhibitor) pharmacotherapy. In studies of SSRIs for HD specifically, response rates are generally in the range of 25–35%, compared to 40–60% for OCD without hoarding.

Saxena et al. (2007) conducted an open-label trial of paroxetine for hoarding disorder (n=79) and found that approximately 36% of completers were rated as "much improved" or "very much improved" on the Clinical Global Impression scale. While this demonstrated that some patients do respond, the effect sizes were modest and the lack of a placebo-controlled design limits interpretation. One randomized trial by Saxena (2011) suggested that paroxetine could be helpful in a subgroup of hoarders, but no large-scale placebo-controlled RCT of any SSRI for HD has been published.

SNRIs and Other Agents

Venlafaxine has been used clinically for HD, particularly given the high comorbidity with depression, but controlled data are lacking. Case reports and small series suggest modest benefit in some patients. Atomoxetine, a selective norepinephrine reuptake inhibitor primarily used for ADHD, has been explored given the attention and executive function deficits in HD, but the only published pilot study (Rodriguez et al., 2013) was inconclusive. Methylphenidate and amphetamine-based stimulants for comorbid ADHD in HD patients represent an interesting but empirically untested strategy; clinical logic suggests that treating attentional deficits could improve organizational capacity and reduce accumulation, but no controlled data exist.

Pharmacotherapy Combined with CBT

The question of whether combined pharmacotherapy and CBT produces better outcomes than either alone has not been rigorously studied in HD specifically. Extrapolating from the OCD literature (e.g., the Foa et al. [2005] study showing CBT > SRI > combination for OCD), the current clinical consensus is that CBT should be the first-line treatment for HD, with pharmacotherapy serving as an adjunct — particularly for comorbid depression, anxiety, or ADHD — rather than a primary treatment. The NNT for pharmacotherapy in HD has not been precisely established but is likely substantially higher (worse) than the NNT of 4–6 estimated for SSRIs in OCD.

Identifying prognostic factors is clinically essential for treatment planning in HD, where outcomes are variable and overall response rates are modest. Research has identified several factors that consistently predict treatment outcome:

Factors Predicting Better Outcome

• Better insight at baseline: This is one of the most robust predictors. Patients with good or fair insight — who acknowledge the problem and its consequences — consistently show better engagement, lower dropout rates, and greater symptom improvement than those with poor or absent insight.
• Higher motivation for change: Related to but distinct from insight. Patients who articulate specific goals for decluttering and who take action on homework assignments in the early sessions are more likely to achieve meaningful change.
• Younger age: Younger patients tend to respond better, likely because their hoarding is less entrenched, they have fewer decades of accumulated possessions, and they may have greater cognitive flexibility. However, most HD patients who present for treatment are middle-aged or older, making this factor difficult to leverage clinically.
• Lower clutter severity at baseline: Patients with moderate rather than extreme clutter show better response, likely reflecting earlier illness stage and less overwhelming task demands.
• Engagement in homework: Across HD treatment studies, homework compliance (especially practicing sorting and discarding between sessions) is strongly predictive of outcome. This is consistent with the broader CBT literature.

Factors Predicting Poorer Outcome

• Comorbid major depression: Depression saps motivation, energy, and decision-making capacity — all essential for HD treatment. Comorbid MDD consistently predicts worse CBT response in HD and may need to be addressed concurrently or prior to HD-focused treatment.
• Older age and longer illness duration: Decades of accumulation create both practical and psychological inertia. Older adults also face physical health limitations that constrain their ability to sort, lift, and transport possessions.
• Involuntary treatment referral: Patients mandated into treatment by courts, housing authorities, or adult protective services tend to have worse outcomes than self-referred patients, though MI can partially bridge this gap.
• Social isolation: Patients with intact social networks show better outcomes, possibly because social contact provides motivation (wanting visitors) and practical support.
• Absence of in-home intervention: Trials that include home visits as part of CBT tend to show better outcomes than those conducted exclusively in office settings.
• Squalor: The presence of squalor (unsanitary conditions, pest infestations, decaying food) as distinct from clutter indicates more severe impairment and potentially reflects different underlying mechanisms (executive dysfunction, depression, self-neglect) that are harder to treat.

A critical clinical reality in HD is that forced or rapid cleanouts — conducted by family members, landlords, or municipal authorities — are generally counterproductive and can be psychologically traumatic. Research by Tolin et al. (2007) and others has documented that forced removal of possessions produces acute grief reactions, exacerbates anxiety and depression, can precipitate suicidal ideation, and is almost invariably followed by rapid re-accumulation (often within 3–6 months). Forced cleanouts should be reserved for genuine safety emergencies (e.g., imminent fire risk, structural collapse, or severe health hazards requiring immediate intervention).

For patients who do not respond adequately to evidence-based treatment — a substantial proportion — harm reduction approaches are increasingly advocated. Harm reduction in HD focuses on maintaining safe pathways through the home ("goat paths"), ensuring access to exits, functional plumbing, safe food preparation areas, and a safe sleeping surface, even if overall clutter levels remain high. This approach borrows from the public health harm reduction framework and is pragmatically appropriate for patients with limited insight, those who decline or drop out of intensive treatment, and those with severe medical comorbidity limiting their ability to engage in active decluttering.

Community-based hoarding task forces — multidisciplinary teams including mental health clinicians, social workers, fire marshals, public health officials, and housing authorities — have proliferated in major cities and represent a systems-level approach to managing the public health consequences of HD. These task forces coordinate assessment, provide graduated interventions, and avoid the fragmented, often punitive approach that historically characterized the community response to hoarding.

Despite significant progress since HD's recognition as a distinct disorder, substantial gaps in the evidence base remain:

• Neuroimaging and biomarker development: While the ACC/insula/vmPFC circuit is well-established, there are no clinically useful biomarkers for HD. No imaging finding can currently diagnose HD or predict treatment response. The field needs larger, better-powered neuroimaging studies with longitudinal designs.
• Pharmacotherapy RCTs: There is a striking absence of large, placebo-controlled RCTs of any medication for HD. The development of pharmacological treatments is arguably the most urgent research need, given that many patients do not respond adequately to CBT alone.
• Digital and technology-assisted interventions: Virtual reality exposure, app-based sorting support, and AI-powered decluttering coaching are in early development. Telehealth delivery of CBT for HD showed promise during the COVID-19 pandemic and may improve access, particularly for homebound older adults.
• Neurostimulation: Transcranial magnetic stimulation (TMS) targeting the dlPFC or ACC is theoretically promising but has barely been studied in HD. Given the response of related conditions (OCD, depression) to TMS and deep brain stimulation, this is an active area of interest.
• Prevention: Given the childhood onset of hoarding tendencies, early identification and intervention programs — particularly for children of parents with HD — represent an untapped prevention opportunity.
• Diverse and representative samples: Most HD research has been conducted with predominantly White, female, treatment-seeking samples in Western countries. The cross-cultural phenomenology of hoarding, its manifestation in non-Western contexts, and how cultural factors influence both symptom expression and treatment response are poorly understood.
• Long-term outcome data: Very few studies follow HD patients beyond 6–12 months post-treatment. Given the chronic and often progressive nature of the disorder, understanding long-term maintenance of gains and relapse rates is essential.

Hoarding disorder is a common, impairing, and undertreated condition with a neurobiology distinct from OCD and a clinical presentation characterized by poor insight, high comorbidity, and chronic course. The following treatment algorithm reflects current evidence and expert consensus:

• Step 1 — Comprehensive assessment: Diagnosis using DSM-5-TR criteria, SI-R/HRS/CIR administration, insight assessment, comorbidity screening (particularly for depression, ADHD, PTSD), home assessment or visual documentation, and functional safety evaluation.
• Step 2 — Motivational enhancement: For patients with poor insight or ambivalence, begin with MI-focused sessions before or integrated with CBT. Expect motivational work to continue throughout treatment.
• Step 3 — CBT using the Steketee-Frost protocol: 20–26 sessions of specialized CBT including cognitive restructuring, skills training, graded exposure to discarding and non-acquiring, and ideally including home visits. Refer to facilitated Buried in Treasures groups when individual therapy is unavailable.
• Step 4 — Adjunctive pharmacotherapy: Consider SSRIs (paroxetine, fluoxetine, sertraline) or venlafaxine for comorbid depression or anxiety. Consider ADHD treatment if comorbid ADHD is present and impairing organizational capacity. Set modest expectations for medication effects on core hoarding symptoms.
• Step 5 — Maintenance and relapse prevention: Booster sessions, ongoing community support (peer groups, task forces), and harm reduction strategies for partial responders.
• Step 6 — For non-responders: Harm reduction focus — ensuring safety, preventing eviction, maintaining basic hygiene and functional living spaces. Consider neurostimulation or novel pharmacological approaches if available through research protocols.

The overall treatment landscape for HD is characterized by moderate but meaningful effectiveness, high variability in individual response, and an urgent need for more potent interventions. Clinicians should be prepared for incremental progress rather than dramatic resolution, should maintain a long-term therapeutic perspective, and should prioritize the therapeutic alliance as perhaps the single most important mediator of change.